Titre : Inhibition nerveuse

Inhibition nerveuse : Questions médicales fréquentes

Termes MeSH sélectionnés :

Randomized Controlled Trials as Topic
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Inhibition nerveuse : Questions médicales les plus fréquentes", "headline": "Inhibition nerveuse : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Inhibition nerveuse : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-01-04", "dateModified": "2025-03-29", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Inhibition nerveuse" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Phénomènes physiologiques du système nerveux", "url": "https://questionsmedicales.fr/mesh/D009424", "about": { "@type": "MedicalCondition", "name": "Phénomènes physiologiques du système nerveux", "code": { "@type": "MedicalCode", "code": "D009424", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "G11.561" } } }, "about": { "@type": "MedicalCondition", "name": "Inhibition nerveuse", "alternateName": "Neural Inhibition", "code": { "@type": "MedicalCode", "code": "D009433", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Chiang-Shan R Li", "url": "https://questionsmedicales.fr/author/Chiang-Shan%20R%20Li", "affiliation": { "@type": "Organization", "name": "Department of Psychiatry, Yale University School of Medicine, New Haven, CT, USA; Department of Neuroscience, Yale University School of Medicine, New Haven, CT, USA; Interdepartmental Neuroscience Program, Yale University School of Medicine, New Haven, CT, USA." } }, { "@type": "Person", "name": "Thang M Le", "url": "https://questionsmedicales.fr/author/Thang%20M%20Le", "affiliation": { "@type": "Organization", "name": "Department of Psychiatry, Yale University School of Medicine, New Haven, CT, USA. Electronic address: thang.le@yale.edu." } }, { "@type": "Person", "name": "Barry R Komisaruk", "url": "https://questionsmedicales.fr/author/Barry%20R%20Komisaruk", "affiliation": { "@type": "Organization", "name": "Department Psychology, Rutgers University, Newark, NJ, USA. Electronic address: brk@psychology.rutgers.edu." } }, { "@type": "Person", "name": "Maria Cruz Rodriguez Del Cerro", "url": "https://questionsmedicales.fr/author/Maria%20Cruz%20Rodriguez%20Del%20Cerro", "affiliation": { "@type": "Organization", "name": "Department Psychobiology, Universidad Nacional de Educación a Distancia, Madrid, Spain." } }, { "@type": "Person", "name": "Sheng Zhang", "url": "https://questionsmedicales.fr/author/Sheng%20Zhang", "affiliation": { "@type": "Organization", "name": "Department of Psychiatry, Yale University School of Medicine, New Haven, CT, USA." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Providing Real-Time Wearable Feedback to Increase Hand Use after Stroke: A Randomized, Controlled Trial.", "datePublished": "2022-09-14", "url": "https://questionsmedicales.fr/article/36146287", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.3390/s22186938" } }, { "@type": "ScholarlyArticle", "name": "A randomized controlled trial of an oral probiotic to reduce antepartum group B Streptococcus colonization and gastrointestinal symptoms.", "datePublished": "2022-09-13", "url": "https://questionsmedicales.fr/article/36108911", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.ajogmf.2022.100748" } }, { "@type": "ScholarlyArticle", "name": "Probiotic effects on sexual function in women with polycystic ovary syndrome: a double blinded randomized controlled trial.", "datePublished": "2022-09-12", "url": "https://questionsmedicales.fr/article/36096842", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1186/s12905-022-01955-z" } }, { "@type": "ScholarlyArticle", "name": "The Efficacy of Integrated Rehabilitation for Post-Stroke Anxiety: Study Protocol for a Prospective, Multicenter, Randomized Controlled Trial.", "datePublished": "2022-09-06", "url": "https://questionsmedicales.fr/article/36097565", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.2147/IJGM.S381434" } }, { "@type": "ScholarlyArticle", "name": "Building elementary students' social and emotional skills: A randomized control trial to evaluate a teacher-led intervention.", "datePublished": "2022-09-02", "url": "https://questionsmedicales.fr/article/36068796", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1007/s12310-022-09538-x" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Phénomènes physiologiques de l'appareil locomoteur et du système nerveux", "item": "https://questionsmedicales.fr/mesh/D055687" }, { "@type": "ListItem", "position": 3, "name": "Phénomènes physiologiques du système nerveux", "item": "https://questionsmedicales.fr/mesh/D009424" }, { "@type": "ListItem", "position": 4, "name": "Inhibition nerveuse", "item": "https://questionsmedicales.fr/mesh/D009433" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Inhibition nerveuse - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Inhibition nerveuse", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-06", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Inhibition nerveuse", "description": "Comment diagnostiquer l'inhibition nerveuse ?\nQuels tests sont utilisés pour l'inhibition nerveuse ?\nQuels signes cliniques indiquent une inhibition nerveuse ?\nL'imagerie est-elle utile pour l'inhibition nerveuse ?\nPeut-on mesurer l'inhibition nerveuse ?", "url": "https://questionsmedicales.fr/mesh/D009433?mesh_terms=Randomized+Controlled+Trials+as+Topic&page=1000#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Inhibition nerveuse", "description": "Quels sont les symptômes de l'inhibition nerveuse ?\nL'inhibition nerveuse cause-t-elle des spasmes musculaires ?\nY a-t-il des symptômes cognitifs associés ?\nComment l'inhibition nerveuse affecte-t-elle la motricité ?\nL'inhibition nerveuse peut-elle causer des troubles sensoriels ?", "url": "https://questionsmedicales.fr/mesh/D009433?mesh_terms=Randomized+Controlled+Trials+as+Topic&page=1000#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Inhibition nerveuse", "description": "Comment prévenir l'inhibition nerveuse ?\nL'exercice régulier aide-t-il à prévenir l'inhibition nerveuse ?\nLes pauses au travail sont-elles importantes ?\nUne alimentation équilibrée peut-elle aider ?\nLe stress influence-t-il l'inhibition nerveuse ?", "url": "https://questionsmedicales.fr/mesh/D009433?mesh_terms=Randomized+Controlled+Trials+as+Topic&page=1000#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Inhibition nerveuse", "description": "Quels traitements existent pour l'inhibition nerveuse ?\nLes médicaments peuvent-ils aider l'inhibition nerveuse ?\nLa physiothérapie est-elle efficace ?\nQuand la chirurgie est-elle envisagée ?\nY a-t-il des thérapies alternatives pour l'inhibition nerveuse ?", "url": "https://questionsmedicales.fr/mesh/D009433?mesh_terms=Randomized+Controlled+Trials+as+Topic&page=1000#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Inhibition nerveuse", "description": "Quelles complications peuvent survenir ?\nL'inhibition nerveuse peut-elle entraîner des handicaps ?\nY a-t-il des risques de dépression associés ?\nDes troubles de la coordination peuvent-ils survenir ?\nL'inhibition nerveuse peut-elle affecter la qualité de vie ?", "url": "https://questionsmedicales.fr/mesh/D009433?mesh_terms=Randomized+Controlled+Trials+as+Topic&page=1000#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Inhibition nerveuse", "description": "Quels sont les facteurs de risque de l'inhibition nerveuse ?\nLe diabète est-il un facteur de risque ?\nLe surpoids influence-t-il l'inhibition nerveuse ?\nLes antécédents familiaux jouent-ils un rôle ?\nLe tabagisme est-il un facteur de risque ?", "url": "https://questionsmedicales.fr/mesh/D009433?mesh_terms=Randomized+Controlled+Trials+as+Topic&page=1000#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment diagnostiquer l'inhibition nerveuse ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Le diagnostic repose sur des examens neurologiques et des tests électrophysiologiques." } }, { "@type": "Question", "name": "Quels tests sont utilisés pour l'inhibition nerveuse ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Les tests incluent l'EMG et les potentiels évoqués pour évaluer la conduction nerveuse." } }, { "@type": "Question", "name": "Quels signes cliniques indiquent une inhibition nerveuse ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Des signes comme la faiblesse musculaire et des réflexes diminués peuvent indiquer une inhibition." } }, { "@type": "Question", "name": "L'imagerie est-elle utile pour l'inhibition nerveuse ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Oui, l'IRM peut aider à visualiser des anomalies structurelles affectant les nerfs." } }, { "@type": "Question", "name": "Peut-on mesurer l'inhibition nerveuse ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des tests spécifiques mesurent l'activité électrique des neurones inhibés." } }, { "@type": "Question", "name": "Quels sont les symptômes de l'inhibition nerveuse ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes incluent douleur, engourdissement, et perte de coordination." } }, { "@type": "Question", "name": "L'inhibition nerveuse cause-t-elle des spasmes musculaires ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elle peut entraîner des spasmes musculaires en raison d'une activité nerveuse altérée." } }, { "@type": "Question", "name": "Y a-t-il des symptômes cognitifs associés ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Des troubles de la concentration et de la mémoire peuvent survenir avec l'inhibition nerveuse." } }, { "@type": "Question", "name": "Comment l'inhibition nerveuse affecte-t-elle la motricité ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Elle peut provoquer une faiblesse musculaire et des difficultés de mouvement." } }, { "@type": "Question", "name": "L'inhibition nerveuse peut-elle causer des troubles sensoriels ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des sensations anormales comme des picotements peuvent se manifester." } }, { "@type": "Question", "name": "Comment prévenir l'inhibition nerveuse ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Maintenir une bonne posture et éviter les mouvements répétitifs peut aider à prévenir." } }, { "@type": "Question", "name": "L'exercice régulier aide-t-il à prévenir l'inhibition nerveuse ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Oui, l'exercice renforce les muscles et améliore la circulation nerveuse." } }, { "@type": "Question", "name": "Les pauses au travail sont-elles importantes ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Oui, faire des pauses régulières réduit le risque de stress nerveux et de blessures." } }, { "@type": "Question", "name": "Une alimentation équilibrée peut-elle aider ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Oui, une alimentation riche en nutriments soutient la santé nerveuse." } }, { "@type": "Question", "name": "Le stress influence-t-il l'inhibition nerveuse ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le stress peut exacerber les symptômes d'inhibition nerveuse." } }, { "@type": "Question", "name": "Quels traitements existent pour l'inhibition nerveuse ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Les traitements incluent la physiothérapie, les médicaments et parfois la chirurgie." } }, { "@type": "Question", "name": "Les médicaments peuvent-ils aider l'inhibition nerveuse ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des analgésiques et des anti-inflammatoires peuvent soulager les symptômes." } }, { "@type": "Question", "name": "La physiothérapie est-elle efficace ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elle aide à renforcer les muscles et améliorer la coordination." } }, { "@type": "Question", "name": "Quand la chirurgie est-elle envisagée ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "La chirurgie est envisagée si les traitements conservateurs échouent ou en cas de compression nerveuse." } }, { "@type": "Question", "name": "Y a-t-il des thérapies alternatives pour l'inhibition nerveuse ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Des thérapies comme l'acupuncture peuvent être bénéfiques pour certains patients." } }, { "@type": "Question", "name": "Quelles complications peuvent survenir ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Des complications incluent des douleurs chroniques et des troubles de la mobilité." } }, { "@type": "Question", "name": "L'inhibition nerveuse peut-elle entraîner des handicaps ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des handicaps fonctionnels peuvent résulter d'une inhibition nerveuse sévère." } }, { "@type": "Question", "name": "Y a-t-il des risques de dépression associés ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Oui, la douleur chronique liée à l'inhibition nerveuse peut contribuer à la dépression." } }, { "@type": "Question", "name": "Des troubles de la coordination peuvent-ils survenir ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Oui, l'inhibition nerveuse peut affecter la coordination et l'équilibre." } }, { "@type": "Question", "name": "L'inhibition nerveuse peut-elle affecter la qualité de vie ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elle peut réduire la qualité de vie en limitant les activités quotidiennes." } }, { "@type": "Question", "name": "Quels sont les facteurs de risque de l'inhibition nerveuse ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Les facteurs incluent l'âge, les blessures, et certaines maladies chroniques." } }, { "@type": "Question", "name": "Le diabète est-il un facteur de risque ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le diabète peut endommager les nerfs et augmenter le risque d'inhibition nerveuse." } }, { "@type": "Question", "name": "Le surpoids influence-t-il l'inhibition nerveuse ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le surpoids peut exercer une pression sur les nerfs, augmentant le risque." } }, { "@type": "Question", "name": "Les antécédents familiaux jouent-ils un rôle ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des antécédents familiaux de troubles nerveux peuvent augmenter le risque." } }, { "@type": "Question", "name": "Le tabagisme est-il un facteur de risque ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le tabagisme peut nuire à la circulation sanguine et affecter les nerfs." } } ] } ] }

Sources (10000 au total)

A randomized controlled trial of an oral probiotic to reduce antepartum group B Streptococcus colonization and gastrointestinal symptoms.

Probiotics have been suggested as a strategy to reduce antenatal group B Streptococcus colonization. Although probiotics are known to improve gastrointestinal symptoms, this has not been studied durin... This study aimed to evaluate the efficacy of a probiotic to reduce: (1) standard-of-care antenatal group B Streptococcus colonization and colony counts and (2) gastrointestinal symptoms of pregnancy.... In a double-blind fashion, 109 healthy adult pregnant people were randomized to Florajen3 probiotic or placebo capsules once daily from 28 weeks' gestation until labor onset. Baseline vaginal and rect... A total of 83 participants completed the study to 36 weeks' gestation with no adverse events. Standard-of-care group B Streptococcus colonization was 20.4% in the control group and 15.4% in probiotic ... The findings of this study provided insufficient evidence for the clinical application of the Florajen3 probiotic intervention to reduce standard-of-care vaginal-rectal group B Streptococcus colonizat...

Probiotic effects on sexual function in women with polycystic ovary syndrome: a double blinded randomized controlled trial.

Considering the presence of sexual dysfunction in patients with polycystic ovary syndrome, our aim was to provide scientific evidence studying effect of oral probiotic on sexual function in patients w... This study was a double blind randomized clinical trial. Eligible women were allocated to Lactofem plus letrozole (n = 20) or letrozole (n = 20). Folic acid was prescribed to all participants in two g... There is statistically significant increase in chemical pregnancy rate (10% vs. 0%; p = 0.05) and clinical pregnancy (10% vs. 0%; p = 0.05) in Probiotic plus letrozole group compared to letrozole grou... The results of the current study suggests that eight weeks of administration of probiotic may improve chemical and clinical pregnancy rate, sexual function and body satisfaction in women with PCOS....

The Efficacy of Integrated Rehabilitation for Post-Stroke Anxiety: Study Protocol for a Prospective, Multicenter, Randomized Controlled Trial.

Post-stroke anxiety (PSA) remains a challenging medical problem. Integrated rehabilitation involves a combination of traditional Chinese medicine (TCM) and Western conventional rehabilitation techniqu... The study is a prospective, multicenter, randomized, controlled trial involving 188 PSA patients from four clinical centers in China. Eligible participants will be randomly divided into the integrated... Results of this trial will ascertain the efficacy and safety of integrated rehabilitation on PSA, thereby providing evidence regarding integrated rehabilitation strategies for treating PSA. It will al... ClinicalTrials.gov NCT05147077....

Ultrasound-guided paravertebral blockade reduced perioperative opioids requirement in pancreatic resection: A randomized controlled trial.

Perioperative opioid use for pain control has been found to be associated with side effects and adverse prognosis. In this study, we hypothesized that paravertebral block could reduce the consumption ... We conducted a prospective, randomized trial. Patients with resectable pancreatic cancer were randomly assigned to one of the two groups: those who received bilateral paravertebral block combined with... A total of 153 patients were enrolled in the study and 119 cases were analyzed. Compared to the control group, patients in PTB patients had significantly lower perioperative (30.81 vs. 56.17 µg), and ... Bilateral paravertebral block combined with general anesthesia reduced the perioperative consumption of opioids by 45%.... ChiCTR1800020291 (available on http://www.chictr.org.cn/)....

Pericapsular nerve group (PENG) block for hip arthroscopy: a randomized, double-blinded, placebo-controlled trial.

Arthroscopic hip surgery is associated with significant postoperative pain. Femoral nerve blocks have been shown to improve postoperative analgesia at the expense of quadriceps weakness. The pericapsu... Subjects presenting for arthroscopic hip surgery were randomized in a 1:1 ratio to either an ultrasound-guided unilateral, single-injection PENG block (PENG group) with 20 mL of 0.5% ropivacaine or a ... Sixty-eight subjects, 34 from the PENG group and 34 from the Sham group, completed the study per protocol. Analysis of the primary outcome demonstrated a mean difference in pain scores of -0.79 (95% C... This study demonstrates that a preoperative PENG block does not improve analgesia following arthroscopic hip surgery.... NCT04508504....

A randomized, double-blind, placebo-controlled phase IIa trial of efruxifermin for patients with compensated NASH cirrhosis.

Efruxifermin has shown clinical efficacy in patients with non-alcoholic steatohepatitis (NASH) and F1-F3 fibrosis. The primary objective of the BALANCED Cohort C was to assess the safety and tolerabil... Patients with NASH and stage 4 fibrosis (n = 30) were randomized 2:1 to receive efruxifermin 50 mg (n = 20) or placebo (n = 10) once-weekly for 16 weeks. The primary endpoint was safety and tolerabili... Efruxifermin was safe and well-tolerated; most adverse events (AEs) were grade 1 (n = 7, 23.3%) or grade 2 (n = 19, 63.3%). The most frequent AEs were gastrointestinal, including transient, mild to mo... Efruxifermin appeared safe and well-tolerated with encouraging improvements in markers of liver injury, fibrosis, and glucose and lipid metabolism following 16 weeks of treatment, warranting confirmat... Cirrhosis resulting from non-alcoholic steatohepatitis (NASH), the progressive form of non-alcoholic fatty liver disease, represents a major unmet medical need. Currently there are no approved drugs f... NCT03976401....